Stay updated on Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page
- Check5 days agoChange DetectedA new revision tag v3.6.2 was added and the old v3.6.0 tag was removed on the page, indicating a small update to the revision history display.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new recruitment-status entry 'No longer looking for participants' was added. The revision was updated to v3.6.0, replacing the prior v3.5.5 entry.SummaryDifference0.3%

- Check26 days agoChange DetectedThe history now includes a new revision entry for v3.5.5, and the previous revision entry v3.5.4 was removed from the current history view.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page's revision tag updates from v3.5.3 to v3.5.4, indicating a newer build of the ClinicalTrials.gov history page. No study data or visible content is altered by this change.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry v3.5.3 is added to the Record History, and the previous revision v3.5.2 is removed from the list.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. The change appears to modify only version metadata and does not alter study records or visible content.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.